{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:00:12Z","timestamp":1781712012022,"version":"3.54.5"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Primary focal segmental glomerulosclerosis (FSGS), typically characterized by diffuse podocyte foot process effacement and nephrotic syndrome (diffuse podocytopathy), is generally attributed to a circulating permeability factor. Primary FSGS can recur after transplantation where it manifests as diffuse foot process effacement in the early stages, with subsequent evolution of segmental sclerotic lesions. Previous published literature has been limited by the lack of stringent selection criteria to define primary FSGS. Although immunogenetic factors play an important role in many glomerular diseases, their role in recurrent primary FSGS post-transplantation has not been systematically investigated. To address this, we retrospectively studied a multicenter cohort of 74 kidney allograft recipients with end stage kidney disease due to primary FSGS, confirmed by clinical and histologic parameters. After adjusting for race\/ethnicity, there was a numeric higher frequency of HLA-A30 antigen in primary FSGS (19%) compared to each of 22,490 healthy controls (7%, adjusted OR=2.0, P=0.04) and 296 deceased kidney donors (10%, OR=2.1, P=0.03). Within the group of transplant patients with end stage kidney disease due to primary FSGS, donor HLA-A30 was associated with recurrent disease (OR=9.1, P=0.02). Multivariable time-to-event analyses revealed that recipients who self-identified as Black people had lower risk of recurrent disease, probably reflecting enrichment of these recipients with <jats:italic>APOL1<\/jats:italic> high-risk genotypes. These findings suggest a role for recipient and donor immunogenetic makeup in recurrent primary FSGS post-transplantation. Further larger studies in well-defined cohorts of primary FSGS that include high-resolution HLA typing and genome-wide association are necessary to refine these hereditary signals.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1124249","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T07:12:32Z","timestamp":1677136352000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Ibrahim","family":"Batal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Khairallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Weins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole K.","family":"Andeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis","volume":"365","author":"D'Agati","year":"2011","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2016.09.21","article-title":"Pathogenesis of focal segmental glomerulosclerosis","volume":"50","author":"Lim","year":"2016","journal-title":"J Pathol Transl Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/6.5.375","article-title":"Two cases of recurrent focal and segmental glomerulosclerosis in renal allografts","volume":"6","author":"Nadasdy","year":"1991","journal-title":"Nephrol Dial Transplant."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.5414\/CNP74173","article-title":"Recurrent focal segmental glomerulosclerosis in the renal allograft: Single center experience in the era of modern immunosuppression","volume":"74","author":"Schachter","year":"2010","journal-title":"Clin Nephrol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.147","article-title":"Minimal change disease and idiopathic FSGS: manifestations of the same disease","volume":"12","author":"Maas","year":"2016","journal-title":"Nat Rev Nephrol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"Kidney disease: Improving global outcomes glomerular diseases work g. KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31990","article-title":"Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease","volume":"190","author":"Sambharia","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X1998000300010","article-title":"Idiopathic focal segmental glomerulosclerosis and HLA antigens","volume":"31","author":"Gerbase-DeLima","year":"1998","journal-title":"Braz J Med Biol Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2015.04.008","article-title":"APOL1 kidney disease risk variants: An evolving landscape","volume":"35","author":"Dummer","year":"2015","journal-title":"Semin Nephrol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00538-3","article-title":"The evolving story of apolipoprotein L1 nephropathy: The end of the beginning","volume":"18","author":"Daneshpajouhnejad","year":"2022","journal-title":"Nat Rev Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/modpathol.2014.92","article-title":"Histopathologic findings associated with APOL1 risk variants in chronic kidney disease","volume":"28","author":"Larsen","year":"2015","journal-title":"Mod Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.01.037","article-title":"Identification of genetic causes of focal segmental glomerulosclerosis increases with proper patient selection","volume":"96","author":"Miao","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08970719","article-title":"Recurrence of FSGS after kidney transplantation in adults","volume":"15","author":"Uffing","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaa110","article-title":"Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers","volume":"14","author":"Jacobs-Cacha","year":"2021","journal-title":"Clin Kidney J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017090958","article-title":"Differentiating primary, genetic, and secondary FSGS in adults: A clinicopathologic approach","volume":"29","author":"De Vriese","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.01.009","article-title":"Association of HLA typing and alloimmunity with posttransplantation membranous nephropathy: A multicenter case series","volume":"76","author":"Batal","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.08.007","article-title":"HLA-d and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients","volume":"99","author":"Berchtold","year":"2021","journal-title":"Kidney Int"},{"key":"B18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000519834","article-title":"Clinical predictors and prognosis of recurrent IgA nephropathy in the kidney allograft","volume":"2","author":"Kavanagh","year":"2022","journal-title":"Glomerular Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2007.04.005","article-title":"High-resolution HLA alleles and haplotypes in the united states population","volume":"68","author":"Maiers","year":"2007","journal-title":"Hum Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07180622","article-title":"The immune system and idiopathic nephrotic syndrome","volume":"17","author":"Campbell","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"100501","DOI":"10.1016\/j.xkme.2022.100501","article-title":"Efficacy and safety of immunosuppressive therapy in primary focal segmental glomerulosclerosis: A systematic review and meta-analysis","volume":"4","author":"Caster","year":"2022","journal-title":"Kidney Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.05.024","article-title":"The role of rituximab in primary focal segmental glomerular sclerosis of the adult","volume":"7","author":"Tedesco","year":"2022","journal-title":"Kidney Int Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018101054","article-title":"Genetic identification of two novel loci associated with steroid-sensitive nephrotic syndrome","volume":"30","author":"Dufek","year":"2019","journal-title":"J Am Soc Nephrol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017111185","article-title":"Transethnic, genome-wide analysis reveals immune-related risk alleles and phenotypic correlates in pediatric steroid-sensitive nephrotic syndrome","volume":"29","author":"Debiec","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017080859","article-title":"Strong association of the HLA-DR\/DQ locus with childhood steroid-sensitive nephrotic syndrome in the Japanese population","volume":"29","author":"Jia","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.05.029","article-title":"Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome","volume":"98","author":"Jia","year":"2020","journal-title":"Kidney Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2215\/CJN.15161219","article-title":"APOL1 nephropathy: From genetics to clinical applications","volume":"16","author":"Friedman","year":"2021","journal-title":"Clin J Am Soc Nephrol."},{"key":"B28","article-title":"Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation","volume":"22","author":"Zimmerman","year":"1984","journal-title":"Clin Nephrol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1202500","article-title":"Resolution of recurrent focal segmental glomerulosclerosis after retransplantation","volume":"366","author":"Gallon","year":"2012","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03060316","article-title":"Long-term outcome of kidney transplantation in recipients with focal segmental glomerulosclerosis","volume":"11","author":"Francis","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31819f12be","article-title":"Kidney transplantation for primary focal segmental glomerulosclerosis: Outcomes and response to therapy for recurrence","volume":"87","author":"Hickson","year":"2009","journal-title":"Transplantation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70010-7","article-title":"Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children","volume":"34","author":"Dall'Amico","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V212s258","article-title":"Recurrence of focal segmental glomerulosclerosis posttransplantation: A special report of the north American pediatric renal transplant cooperative study","volume":"2","author":"Tejani","year":"1992","journal-title":"J Am Soc Nephrol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.2001.057004344.x","article-title":"Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure","volume":"57","author":"Doxiadis","year":"2001","journal-title":"Tissue Antigens"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)92118-4","article-title":"Strong association between idiopathic membranous nephropathy and HLA-DRW3","volume":"2","author":"Klouda","year":"1979","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00720.x","article-title":"The HLA complex in goodpasture's disease: a model for analyzing susceptibility to autoimmunity","volume":"56","author":"Phelps","year":"1999","journal-title":"Kidney Int"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.05.010","article-title":"Fibrillary glomerulonephritis is associated with HLA-DR7 and HLA-B35 antigens","volume":"5","author":"Andeen","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001201","article-title":"HLA loci and recurrence of focal segmental glomerulosclerosis in pediatric kidney transplantation","volume":"7","author":"Shaw","year":"2021","journal-title":"Transplant Direct."},{"key":"B39","article-title":"[Association of HLA-A0205 and HLA-A30 with latent autoimmune diabetes in adults]","volume":"27","author":"Deng","year":"2010","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi."},{"key":"B40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1399-0004.1991.tb02984.x","article-title":"Age of onset in vitiligo: relationship with HLA supratypes","volume":"39","author":"Finco","year":"1991","journal-title":"Clin Genet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/301415","article-title":"HLA markers for poor prognosis in systemic sclerosis Brazilian patients","volume":"35","author":"Del Rio","year":"2013","journal-title":"Dis Markers."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012020133","article-title":"Podocytes are nonhematopoietic professional antigen-presenting cells","volume":"24","author":"Goldwich","year":"2013","journal-title":"J Am Soc Nephrol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.21311","article-title":"Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the united states","volume":"37","author":"Abbott","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31829c2431","article-title":"Focal segmental glomerulosclerosis in children: multivariate analysis indicates that donor type does not alter recurrence risk","volume":"96","author":"Nehus","year":"2013","journal-title":"Transplantation"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.06.024","article-title":"Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts","volume":"94","author":"Santoriello","year":"2018","journal-title":"Kidney Int"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003432","article-title":"De novo focal and segmental glomerulosclerosis after COVID-19 in a patient with a transplanted kidney from a donor with a high-risk APOL1 variant","volume":"105","author":"Oniszczuk","year":"2021","journal-title":"Transplantation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.semnephrol.2022.01.005","article-title":"Glomerular diseases of the kidney allograft: Toward a precision medicine approach","volume":"42","author":"Zanoni","year":"2022","journal-title":"Semin Nephrol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1124249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T07:12:35Z","timestamp":1677136355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1124249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2023.1124249"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1124249","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"article-number":"1124249"}}